Q3 2023 Holdings
Filed 2023-11-14 | 26 holdings | $679.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Structure Therapeutics Inc(GPCR) | ADRS | 86366E106 | $75.8M | 1,502,747 | 11.2% |
| Cogent Biosciences Inc(COGT) | COMM | 19240Q201 | $54.9M | 5,631,042 | 8.1% |
| Geron Corp(GERN) | COMM | 374163103 | $49.6M | 23,375,839 | 7.3% |
| An2 Therapeutics, Inc.(ANTX) | COMM | 037326105 | $43.1M | 2,678,209 | 6.3% |
| Savara Inc.(SVRA) | COMM | 805111101 | $37.8M | 10,000,000 | 5.6% |
| Taysha Gene Therapies, Inc.(TSHA) | COMM | 877619106 | $35.1M | 11,111,111 | 5.2% |
| Kalvista Pharmaceuticals, Inc(KALV) | COMM | 483497103 | $32.7M | 3,395,495 | 4.8% |
| Inhibrx,inc(INBXUSD) | COMM | 45720L107 | $32.1M | 1,750,387 | 4.7% |
| Aerovate Therapeutics Inc | COMM | 008064107 | $29.9M | 2,201,274 | 4.4% |
| Icosavax, Inc. | COMM | 45114M109 | $28.7M | 3,703,704 | 4.2% |
| Compass Pathways PLC(CMPS) | ADRS | 20451W101 | $28.5M | 3,858,000 | 4.2% |
| Ventyx Biosciences, Inc(VTYX) | COMM | 92332V107 | $28.3M | 815,724 | 4.2% |
| Tyra Biosciences Inc(TYRA) | COMM | 90240B106 | $27.4M | 1,989,103 | 4.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COMM | 558868105 | $26.3M | 179,917 | 3.9% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $20.7M | 2,104,875 | 3.0% |
| Tarsus Pharmaceuticals, Inc.(TARS) | COMM | 87650L103 | $20.3M | 1,142,857 | 3.0% |
| Rayzebio, Inc. | COMM | 75525N107 | $19.3M | 869,908 | 2.8% |
| Dyne Therapeutics, Inc(DYN) | COMM | 26818M108 | $14.8M | 1,650,150 | 2.2% |
| Centessa Pharmaceuticals PLC(CNTA) | COMM | 152309100 | $13.2M | 2,040,816 | 1.9% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $13.0M | 1,423,642 | 1.9% |
| Immunovant, Inc(IMVT) | COMM | 45258J102 | $12.9M | 334,853 | 1.9% |
| Entrada Therapeutics Inc(TRDA) | COMM | 29384C108 | $9.2M | 584,955 | 1.4% |
| Gracell Biotechnologies Inc. | ADRS | 38406L103 | $8.8M | 3,038,889 | 1.3% |
| Cabaletta BIO, Inc(CABA) | COMM | 12674W109 | $7.4M | 486,795 | 1.1% |
| Merus N.V. | COMM | N5749R100 | $7.1M | 300,000 | 1.0% |
| C4 Therapeutics, Inc.(CCCC) | COMM | 12529R107 | $2.4M | 1,276,574 | 0.3% |